AI as an Aid for Weekly Symptom Intake in Radiotherapy
Evaluation of AI-Enhanced Symptom Summarization in Weekly Radiotherapy Consultations: A Comparative Study
jaide
200 participants
Jul 22, 2024
INTERVENTIONAL
Conditions
Summary
The study investigates the use of artificial intelligence (AI) and large language models (LLMs) to enhance the efficiency and accuracy of weekly treatment consultations (OTVs) in radiotherapy. It hypothesizes that an AI-enabled symptom summary tool will match traditional medical review methods in accuracy while saving time. The study includes patients undergoing pelvic radiotherapy and excludes those with pelvic reirradiation or who have undergone surgery. Patients will receive both standard and AI-assisted weekly consultations, with AI summaries generated using the OpenAI GPT-4 API. Blinded oncologists will compare the accuracy and quality of the AI-generated and doctor-generated summaries, while patients and doctors will rate these summaries. The primary objective is to evaluate the accuracy and time efficiency of AI-assisted symptom summaries compared to traditional methods.
Eligibility
Inclusion Criteria1
- All patients undergoing radiotherapy in the pelvic region.
Exclusion Criteria1
- Cases of pelvic reirradiation or operated cases.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Gen AI assisted symptom intake summarization
Standard weekly symptom intake performed by a physician
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06525181